Thailand's Food and Drug Administration approves the emergency use of the Oxford–AstraZeneca COVID-19 vaccine. 50,000 doses of the vaccine are expected to arrive in February
Thailand's Food and Drug Administration approves the emergency use of the Oxford–AstraZeneca COVID-19 vaccine. 50,000 doses of the vaccine are expected to arrive in February.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthThailand's Food and Drug Administration approves the emergency use of the Oxford–AstraZeneca COVID-19 vaccine. 50,000 doses of the vaccine are expected to arrive in February
View Premium plansBrowse free archive reportsThailand's Food and Drug Administration approves the emergency use of the Oxford–AstraZeneca COVID-19 vaccine. 50,000 doses of the vaccine are expected to arrive in February.